Loading...
Market
What will Abbott Laboratories' full-year 2024 organic sales growth be?
3
Resolution / Starting Odds
Below 9.5% • 25%
9.5% - 9.6% • 25%
9.7% - 9.8% • 25%
9.9% - 10.0% • 25%
Abbott Laboratories' full-year 2024 earnings report
Story
Abbott Labs Raises Full-Year Guidance After Beating Q2 Estimates with $1.14 EPS and $10.38B Revenue
Jul 18, 2024, 11:36 AM
Abbott Laboratories reported strong second-quarter 2024 earnings, surpassing Wall Street estimates. The company's adjusted earnings per share (EPS) stood at $1.14, exceeding the forecast of $1.10. Revenue for the quarter was $10.38 billion, slightly above the estimated $10.37 billion. The robust performance was driven by strong sales in its medical devices segment, particularly cardiac and diabetes care devices. As a result, Abbott raised its full-year 2024 profit guidance. The company now expects full-year adjusted EPS to be between $4.61 and $4.71, up from the previous range of $4.55 to $4.70. Additionally, Abbott projects third-quarter GAAP EPS to be between $0.85 and $0.89 and adjusted EPS to be between $1.18 and $1.22. The second-quarter GAAP diluted EPS was $0.74. Abbott also forecasts full-year organic sales growth of 9.5% to 10.0%. The CEO highlighted the company's positive momentum heading into the second half of the year.
View original story
Similar markets
< 0% • 25%
0% to 0.5% • 25%
0.6% to 1% • 25%
> 1% • 25%
Less than 3% • 25%
3% to 4% • 25%
4% to 5% • 25%
More than 5% • 25%
Outperform • 25%
Underperform • 25%
Match performance • 25%
Significantly underperform • 25%
< 0% • 25%
0% to 1% • 25%
1% to 2% • 25%
> 2% • 25%
5.7% to 6.2% • 25%
Less than 5.7% • 25%
More than 6.2% • 25%
Other • 25%
10-15% • 25%
0-5% • 25%
5-10% • 25%
15% or more • 25%
Below 10% • 25%
10% to 15% • 25%
15% to 20% • 25%
Above 20% • 25%
Negative growth • 25%
0-5% growth • 25%
5-10% growth • 25%
Over 10% growth • 25%
Below $45 billion • 25%
$45 billion to $45.5 billion • 25%
$45.5 billion to $46 billion • 25%
Above $46 billion • 25%
Less than 5% • 25%
5% to 10% • 25%
10% to 15% • 25%
More than 15% • 25%
Less than 20% • 25%
20% to 30% • 25%
30% to 40% • 25%
More than 40% • 25%
0-5% • 25%
6-10% • 25%
11-15% • 25%
Over 15% • 25%